Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients
Polina Len, Gaukhar Iskakova, Zarina Sautbayeva, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 24

Showing 24 citing articles:

Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness
Lize M. Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 48, Iss. 07, pp. 858-868
Open Access | Times Cited: 42
Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation
Marco Vettori, Giovanni Carpenè, Gian Luca Salvagno, et al.
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 02, pp. 275-283
Closed Access | Times Cited: 10
Hemostatic and liver function parameters as COVID-19 severity markers
Q Iqbal, Mudatsir Mudatsir, Harapan Harapan, et al.
Narra J (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 2
The association between mortality due to COVID-19 and coagulative parameters: a systematic review and meta-analysis study
Alireza Abdollahi, Saeed Nateghi, Zahra Panahi, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Curtailing virus-induced inflammation in respiratory infections: emerging strategies for therapeutic interventions
Alexander A. Globenko, Gennady V. Kuzin, Anastasia V. Rydlovskaya, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
Parastoo Yousefi, Saber Soltani, Goli Siri, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 11-12
Open Access | Times Cited: 7
Complex Pattern of Platelet Activation/Reactivity After SARS-CoV-2 Infection
Bogusława Luzak, Jacek Golański, M. Różalski
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 49-49
Open Access | Times Cited: 1
Hematological and Biochemical Laboratory Parameters in COVID-19 Patients: A Retrospective Modeling Study of Severity and Mortality Predictors
Ghazaleh Alizad, Ali Asghar Ayatollahi, Armin Shariati Samani, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 4
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study
Emily Córneo, Rafael Garbelotto, Gabriele da Silveira Prestes, et al.
Thrombosis Journal (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
The Association of PLAUR Genotype and Soluble suPAR Serum Level with COVID-19-Related Lung Damage Severity
Ludmila A. Nekrasova, Anna Shmakova, L. М. Samokhodskaya, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16210-16210
Open Access | Times Cited: 5
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection
Danilo Malandrino, A. Berni, Benedetta Fibbi, et al.
Journal of Endocrinological Investigation (2022) Vol. 46, Iss. 3, pp. 577-586
Open Access | Times Cited: 4
Hematologic tests and their association with the severity of COVID-19 and periodontitis in hospitalized patients: a case–control study
Janet Moradi Haghgoo, Parviz Torkzaban, Maryam Farhadian, et al.
BMC Oral Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Thrombosis and coagulopathy in COVID-19: A current narrative
Alejandro Lazo‐Langner, Mateo Porres‐Aguilar
Elsevier eBooks (2024), pp. 337-348
Closed Access
Unveiling coagulation dysfunction in patients with COVID-19: a retrospective analysis
Ahmed Ali Jerah, Abdullah Farasani, Hisham Abu-Tawil, et al.
Journal of Medicine and Life (2024) Vol. 17, Iss. 9, pp. 886-891
Open Access
Beyond the Acute Phase: Long-Term Impact of COVID-19 on Functional Capacity and Prothrombotic Risk—A Pilot Study
Doina-Clementina Cojocaru, Florin Mitu, Maria‐Magdalena Leon, et al.
Medicina (2023) Vol. 60, Iss. 1, pp. 51-51
Open Access | Times Cited: 1
Relative hypercoagulopathy of the SARS-CoV-2 Beta and Delta variants when compared to the less severe Omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness.
Lize M. Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Prolonged Elevations of Factor VIII and von Willebrand Factor Antigen After Multisystem Inflammatory Syndrome in Children
Alexander A. Boucher, Stacie Knutson, Luke Young, et al.
Journal of Pediatric Hematology/Oncology (2022) Vol. 45, Iss. 4, pp. e427-e432
Closed Access | Times Cited: 2
Association of Lung Fibrotic Changes and Cardiological Dysfunction with Hypertension in Long COVID-19 cohort
Ainur Tauekelova, Zhanar Kalila, Bakhtiyar Akerke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
FEATURES OF COAGULOPATHY AND SYSTEMIC INFLAMMATION IN PATIENTS AFTER COVID-19 INFECTION
Dmytrii I. Mykhalchuk, Serhij A. Pavlovskyi, M. O. Pavlovskа, et al.
Wiadomości Lekarskie (2022) Vol. 75, Iss. 12, pp. 2907-2914
Closed Access | Times Cited: 1
Association of Lung Fibrotic Changes and Cardiological Dysfunction with Comorbidities in Long COVID-19 Cohort
Ainur Tauekelova, Zhanar Kalila, Akerke Bakhtiyar, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2567-2567
Open Access
COVID-19: Epidemiology, Etiology, Clinical Manifestations, Diagnosis, Therapeutic Options, and Prevention
Jaime E. Mogollon, Ghaleb Halaseh, Neeraja Swaminathan
Contemporary Endocrinology (2023), pp. 3-18
Closed Access
Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial
Thor Ueland, Annika E. Michelsen, Anders Tveita, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 8, Iss. 1, pp. 102289-102289
Open Access
The unique landscape of coronavirus disease 2019 coagulopathy and imminent bleedings at unusual sites: Pathophysiology matters
Eleni Paschou, Achilleas Betsikos, Georgios Zagkotsis, et al.
Current Urology (2022)
Open Access
Risiko Perdarahan Saluran Cerna pada Pasien COVID-19 berdasarkan Jenis Obat Antivirus di Rumah Sakit Umum Pusat Dr. M. Djamil Padang
Arnelis Arnelis, Saptino Miro, Nasrul Zubir, et al.
Jurnal Kesehatan Andalas (2022) Vol. 11, Iss. 2, pp. 72-72
Open Access
Page 1

Scroll to top